BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4816977)

  • 41. FDA recommends hepatitis B drug.
    AIDS Patient Care STDS; 2002 Oct; 16(10):511. PubMed ID: 12437861
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comparison of peg-interferon monotherapy to peg-interferon and nucleoside analogue combination therapy for hepatitis B: a meta-analysis of randomized controlled trials].
    Li MY; Yuan XL; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):442-7. PubMed ID: 23044202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Developmental aspects of adenine arabinoside for parenteral therapy of human herpesvirus infections.
    Whitley RJ; Alford CA
    Adv Ophthalmol; 1979; 38():288-96. PubMed ID: 230722
    [No Abstract]   [Full Text] [Related]  

  • 44. Acyclovir treatment of herpes zoster infections. Use in children undergoing bone marrow transplantation.
    Serota FT; Starr SE; Bryan CK; Koch PA; Plotkin SA; August CS
    JAMA; 1982 Apr; 247(15):2132-5. PubMed ID: 7038177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Question of the month: should herpes zoster in an immunocompetent subject (except ocular herpes zoster) be treated by antiviral agents?].
    Ann Dermatol Venereol; 1997; 124(4):366-9. PubMed ID: 9739950
    [No Abstract]   [Full Text] [Related]  

  • 46. Herpes zoster guidelines of the German Dermatological Society.
    Gross G; Doerr HW
    J Clin Virol; 2003 Aug; 27(3):308-9. PubMed ID: 12878095
    [No Abstract]   [Full Text] [Related]  

  • 47. Adenine arabinoside in idoxuridine unresponsive and intolerant herpetic keratitis.
    Hyndiuk RA; Hull DS; Schultz RO; Chin GN
    Am J Ophthalmol; 1975 Apr; 79(4):655-8. PubMed ID: 123413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New treatment of chronic hepatitis B].
    Andersen ES; Weis NM
    Ugeskr Laeger; 2008 Nov; 170(48):3937-9. PubMed ID: 19087730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Therapy of herpes zoster].
    Engst R
    Z Hautkr; 1989 Oct; 64(10):848-50. PubMed ID: 2686242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunocompromised patients, herpes zoster and acyclovir.
    Elder M; Thomas MG; Ellis-Pegler RB
    N Z Med J; 1996 May; 109(1022):196. PubMed ID: 8657394
    [No Abstract]   [Full Text] [Related]  

  • 51. Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.
    de Clercq E; Degreef H; Wildiers J; de Jonge G; Drochmans A; Descamps J; de Somer P
    Br Med J; 1980 Nov; 281(6249):1178. PubMed ID: 7427624
    [No Abstract]   [Full Text] [Related]  

  • 52. Famciclovir approved for shingles.
    Nurse Pract; 1995 Jan; 20(1):80. PubMed ID: 7898796
    [No Abstract]   [Full Text] [Related]  

  • 53. Herpes zoster and postherpetic neuralgia: prevention and management.
    Mounsey AL; Matthew LG; Slawson DC
    Am Fam Physician; 2005 Sep; 72(6):1075-80. PubMed ID: 16190505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Herpes zoster and diabetes.
    Kalra S; Chawla A
    J Pak Med Assoc; 2016 Aug; 66(8):1042-3. PubMed ID: 27524548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current status of antiviral chemotherapy.
    Whitley RJ; Alford CA
    South Med J; 1978 Sep; 71(9):1134-40. PubMed ID: 210524
    [No Abstract]   [Full Text] [Related]  

  • 56. Bilateral disseminated herpes zoster in an immunocompetent host.
    Takaoka Y; Miyachi Y; Yoshikawa Y; Tanioka M; Fujisawa A; Endo Y
    Dermatol Online J; 2013 Feb; 19(2):13. PubMed ID: 23473283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.
    Shafran SD; Tyring SK; Ashton R; Decroix J; Forszpaniak C; Wade A; Paulet C; Candaele D
    J Clin Virol; 2004 Apr; 29(4):248-53. PubMed ID: 15018852
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management issues in herpes zoster.
    Dwyer DE
    Aust Fam Physician; 1996 Mar; 25(3):299-307. PubMed ID: 8867180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A pharmacokinetic and safety evaluation of a 28 day course of oral acyclovir in elderly patients with herpes zoster.
    Moss PJ; Wood MJ; Crooks RJ; Gallagher J; McKendrick MW
    J Antimicrob Chemother; 1995 Jul; 36(1):271-3. PubMed ID: 8537281
    [No Abstract]   [Full Text] [Related]  

  • 60. Recurrence of herpes zoster in an immunocompetent adult male.
    Raza N; Iqbal P; Anwer J
    J Ayub Med Coll Abbottabad; 2005; 17(3):80-1. PubMed ID: 16320806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.